The use of the Calvert formula to determine the optimal carboplatin dosage
- 1 August 1995
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 121 (8), 478-486
- https://doi.org/10.1007/bf01218365
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Is creatinine clearance a sufficient measurement for GFR in carboplatin dose calculation?European Journal of Cancer, 1993
- Carboplatin versus cisplatinAnnals of Oncology, 1993
- Renal handling of carboplatinCancer Chemotherapy and Pharmacology, 1992
- Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.BMJ, 1991
- Clinical Pharmacokinetics of CarboplatinClinical Pharmacokinetics, 1991
- Carboplatin dose in combination chemotherapy for testicular cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Carboplatin and etoposide pharmacokinetics in patients with testicular teratomaCancer Chemotherapy and Pharmacology, 1989
- CarboplatinDrugs, 1989
- Calculation of 51Cr‐EDTA clearance in children from the activity in one plasma sample by transformation of the biexponential plasma time‐activity curve into a monoexponential with identical integral area below the time‐activity curveClinical Physiology and Functional Imaging, 1984
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976